MS Therapy Management for Pregnancy May Raise Relapse Risk

(MedPage Today) — Management of disease-modifying therapies (DMTs) for multiple sclerosis (MS) during pregnancy raised relapse risk, especially for certain drugs, French registry data suggested.
Across all MS drugs, DMT management during pregnancy…